APG Asset Management
BIVV

APG Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

APG Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-780,100
Closed -$35M – 856
2017
Q4 		$35M Buy
780,100
+726,700
+1,361% +$39.8M 0.06% 295
2017
Q3 		$3.05M Sell
53,400
-17,045
-24% -$998K 0.01% 700
2017
Q2 		$4.24M Sell
70,445
-24,559
-26% -$1.4M 0.01% 596
2017
Q1 		$5.17M Buy
+95,004
New +$4.68M 0.01% 589

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

APG Asset Management's BIVV Position: Q1 2018 in Review

APG Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 780,100 shares — an estimated $35M sold.

APG Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $35M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • APG Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • APG Asset Management sold 780,100 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $35M.
  • APG Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • APG Asset Management's Bioverativ Inc. Common Stock position peaked at $35M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on APG Asset Management's 13F filing for Q1 2018, filed 14 May 2018.